Premium
O4‐08‐03: PSYCHOSOCIAL OUTCOMES OF APOE E4 GENOTYPE DISCLOSURE IN THE GENERATION STUDY
Author(s) -
Bradbury Angela R.,
Karlawish Jason,
Roberts J Scott,
Egleston Brian L.,
Patrick-Miller Linda,
McCarty Wood Elisabeth,
Kim Scott YH.,
Jaeger Jan,
Reddy Neeraja,
Cacioppo Cara,
Henry-Moss Dare,
Jideama Stephanie,
Ofidis Demetrios,
Liu Fonda,
Caputo Angelika,
Riviere Marie-Emmanuelle,
Bezuidenhoudt Mauritz,
Langlois Carolyn,
Reiman Eric M.,
Tariot Pierre N.,
Langbaum Jessica B.
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.2953
Subject(s) - psychosocial , anxiety , apolipoprotein e , clinical psychology , disease , distress , psychology , medicine , genotype , depression (economics) , psychiatry , genetics , biology , macroeconomics , economics , gene
O4-08-03 PSYCHOSOCIAL OUTCOMES OF APOE E4 GENOTYPE DISCLOSURE IN THE GENERATION STUDY Angela R. Bradbury, Jason Karlawish, J Scott Roberts, Brian L. Egleston, Linda Patrick-Miller, Elisabeth McCarty Wood, Scott YH. Kim, Jan Jaeger, Neeraja Reddy, Cara Cacioppo, Dare Henry-Moss, Stephanie Jideama, Demetrios Ofidis, Fonda Liu, Angelika Caputo, Marie-Emmanuelle Riviere, Mauritz Bezuidenhoudt, Carolyn Langlois, Eric M. Reiman, Pierre N. Tariot, Jessica B. Langbaum, University of Pennsylvania, Philadelphia, PA, USA; University of Michigan, Ann Arbor, MI, USA; Fox Chase Cancer Center, Philadelphia, PA, USA; Independent Consultant, Chicago, IL, USA; National Institutes of Health, Bethesda, MD, USA; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA; Novartis Pharma AG, Basel, Switzerland; Novartis Pharma, Basel, Switzerland; Banner Alzheimer’s Institute, Phoenix, AZ, USA; Arizona Alzheimer’s Consortium, Phoenix, AZ, USA. Contact e-mail: angela.bradbury@uphs.upenn.edu